October 2025 in “Cosmetics” Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.
September 2025 in “Cureus” Plica neuropathica can occur with diffuse alopecia and should be considered in diagnosis.
September 2025 in “Current Oncology” LncRNAs may help improve brain cancer treatment and diagnosis.
September 2025 in “International Journal of Medical Informatics” A machine learning model can predict scarring in lichen planopilaris using factors like vitamin D levels and diagnostic delay.
September 2025 in “International Journal of Molecular Sciences” International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.
Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.
June 2025 in “Journal of Face Aesthetics” Accurate diagnosis of facial blistering diseases is crucial for effective treatment.
Stem cell treatments show promise for improving skin and hair, but need more research and standardization.
AI can personalize exercise routines to improve skin health.
May 2025 in “International Journal of Trichology” Low-dose oral minoxidil often causes excess hair growth but doesn't significantly affect quality of life.
April 2025 in “Dermatology and Therapy” Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.
Finasteride can cause long-term side effects like sexual dysfunction and depression.
February 2025 in “Jurnal Kedokteran Brawijaya” Autologous skin cell transplantation speeds up healing and xenografts improve skin color in burn care.
February 2025 in “Endocrine Reviews” Hormones affect skin aging, but only topical retinoids and estrogens are used in treatments now.
February 2025 in “International Journal of Dermatology” Pressure from injectable treatments can cause hair loss by compressing blood vessels.
February 2025 in “Journal of the European Academy of Dermatology and Venereology” UVFD helps detect hair follicles in alopecia areata better than traditional methods.
January 2025 in “HORMONES” Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.
Androgenetic alopecia in young males leads to lower self-esteem, increased anxiety, and higher depression risk.
November 2024 in “JAMA Dermatology” Low-dose oral minoxidil may help with hair loss, but more research is needed.
November 2024 in “Fizioterapevt (Physiotherapist)” Combined therapy is highly effective for treating diffuse alopecia.
October 2024 in “Journal of Cosmetic Dermatology” The metaverse offers potential for managing hair and nail disorders but faces challenges like technology limits and accessibility.
September 2024 in “Revista Foco” Platelet-Rich Plasma (PRP) is a safe and effective tool for facial rejuvenation and scar treatment.
September 2024 in “Archiv Euromedica” Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.
August 2024 in “Cosmetics” Personalized treatments for hair loss are becoming more effective by using genetic information.
August 2024 in “Dermatological Reviews” New technologies are improving the diagnosis and treatment of hair and nail disorders.
August 2024 in “Journal of Biomedical Research & Environmental Sciences” Low SHBG levels are linked to negative health outcomes and should be used in assessing and managing health conditions.
June 2024 in “Journal of cosmetic dermatology” Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.
April 2024 in “Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME)” Mesotherapy can be beneficial but has risks if misused.
April 2024 in “Journal of composites science” Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.
March 2024 in “Drug development & registration” Mesenchymal stem cell secretome shows promise for skin treatments but needs more human trials.